Position in OVID
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,889
+$5,542 QoQ
Shares Held
4,792
+44.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#111
of 131 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OVID Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $2,116,200,383 across 427 Biotechnology names. OVID ranks #260 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
6,182,479 | $490,208,754 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
980,259 | $486,924,048 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
875,859 | $263,659,830 | |
| 4 | INCY |
Incyte Corp
|
1,132,050 | $128,329,182 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
174,515 | $108,817,078 | |
| 6 | MRNA |
Moderna, Inc.
|
944,457 | $66,140,319 | |
| 7 | INSM |
INSMED Inc
|
416,487 | $44,405,840 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
545,761 | $42,716,712 |
All Filings in OVID
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,889 | 4,792 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $7,347 | 3,310 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,752 | 1,075 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $5,958 | 4,584 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,235 | 6,778 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $1,800 | 5,774 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $1,584 | 1,697 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $6,090 | 5,162 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,259 | 5,539 | Shares | Sole | 2024-11-06 | |
| 2024-03-31 | $6,880 | 2,256 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $75,279 | 23,379 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $49,224 | 12,819 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $20,404 | 6,221 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $147 | 57 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $104 | 56 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $843 | 459 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $3,014 | 960 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,815 | 1,500 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $25,200 | 7,500 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $96,658 | 24,721 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $300,784 | 74,822 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $190,114 | 82,301 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $2,408,452 | 419,591 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $888,011 | 120,490 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $21,229 | 7,124 | Shares | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||